The Food and Drug Administration (FDA) issued an updated draft on the "Quality System Considerations and Content of Premarket Submissions" guidance to address cybersecurity for medical devices in late April 2022, currently in comment period until July, and expected to be finalized by late 2022. The proposed changes will update and supersede the 2014 and 2018 Guidance documents. Online threats to the healthcare sector have become more frequent and more severe, carrying increased potential for clinical impact. Cybersecurity incidents have rendered medical devices and hospital networks inoperable, disrupting the delivery of patient care across healthcare facilities in the U.S. and globally.
Join us to gain an understanding of the changes being proposed in the cybersecurity program for medical devices and the potential impact to medical product development process and to the 510(k) pre-market submissions. While this is a draft, it will be helpful to understand how many of these changes may be helpful for safely operating medical device systems. These systems can include health care facility networks, other devices, and other interconnected components. As a result, ensuring device cyber safety and effectiveness is a key to ensuring the safety and security of the patient.
Key Learning Points:
- Process changes to medical device development
- Impact on cybersecurity design and testing of devices and services
- Requirements for 501(k) pre-submission and pre-market approval (PMA)
- Determine if you need to make comments to the FDA draft guidance